Risk Sharing and Innovative Contracting with CROs
Pharmaceutical Pricing Strategy: Maximize Revenue in an Evolving Economic Climate
Strategic Pharmaceutical Competitive Intelligence Improve Market Research Impact
Health Outcomes Liaisons: Managing a Field-Based Team That Speaks the Payer’s Language
2012 Medicines in Development for Cancer report
PhRMA’s 2012 Medicines in Development for Cancer report includes information on new oncology drugs in the pipeline and their current development status. The report is broken down by type of cancer and is followed by additional fact sheets and other helpful resources. Our goal is that the report not […]
Health Economics and Outcomes Research
Opportunities in Emerging Markets-Developing Asia
Country Reports: The healthcare market in Japan
The Managed Care Injectables Index (The Zitter Group)
[…]
Real World Data and its Healthcare Applications Report
The most comprehensive and detailed report on RWDs sources, partnerships, usage and regulations in relation to how they can help pharma satisfy payor needs and achieve reimbursement for new treatments. Download full report here. (Source: eyeforpharma, 2013). […]
